Dexcom Inc. buy tbackenh
Start price
09.02.21
/
70%
€82.24
Target price
09.02.22
€87.50
Performance (%)
29.20%
End price
12.08.21
€106.25
Summary
This prediction ended on 12.08.21 with a price of €106.25. The prediction had a final performance of 29.20%. tbackenh has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Dexcom Inc. | 2.954% | 2.954% | -21.029% | -47.076% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to tbackenh what are the pros and cons of Dexcom Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Some uniques
Cons
Higher risks for its business
High valuation
Comments by tbackenh for this prediction
In the thread Dexcom Inc. diskutieren
DEXCOM – der Anbieter für kontinuierliche Gewebeglukosemessung in Echtzeit. In den Industrieländern steigt die Zahl der Zuckerkranken immer weiter und digitale Glukosemessungen in Zeiten der Pandemie schaffen eine Win-Win-Situation auf beiden Seiten.
In the thread Trading Dexcom Inc.
Buy beendet